MaxCyte Inc
LSE:MXCT
MaxCyte Inc
EPS (Diluted)
MaxCyte Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MaxCyte Inc
LSE:MXCT
|
EPS (Diluted)
$0
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
EPS (Diluted)
$15
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
Danaher Corp
NYSE:DHR
|
EPS (Diluted)
$10
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
EPS (Diluted)
$36
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Agilent Technologies Inc
NYSE:A
|
EPS (Diluted)
$4
|
CAGR 3-Years
17%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
EPS (Diluted)
$7
|
CAGR 3-Years
72%
|
CAGR 5-Years
43%
|
CAGR 10-Years
16%
|
See Also
What is MaxCyte Inc's EPS (Diluted)?
EPS (Diluted)
-0.4
USD
Based on the financial report for Dec 31, 2023, MaxCyte Inc's EPS (Diluted) amounts to -0.4 USD.
What is MaxCyte Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-17%
Over the last year, the EPS (Diluted) growth was -61%. The average annual EPS (Diluted) growth rates for MaxCyte Inc have been -30% over the past three years , -17% over the past five years .